All posts tagged
A Cure for Cancer? How CAR-T Therapy is Revolutionizing Oncology
The 8 Biggest Biotech Medical Fails of 2016 in Europe
What do the CAR-T Patient Deaths Mean for the Future of the Field?
Debunking the Immuno-Oncology Hype: is it as good as it sounds?
UPDATED: Storm on the CAR-T field – 3 patients die in Phase II Study
Ultimate Review: CAR-T is The Game-changer in Cancer Treatments
Cellectis’ Miraculous Saving of a Baby Girl. What’s the impact on the CAR-T field?
ERRATUM: Celyad’s US patent on TCR-deficient allogeneic CAR-T cells
CRISPR Therapeutics reinforces its Team with Top Executives from Pfizer and McKinsey
Labiotech UG, All Rights Reserved -
Send this to a friend